Sreekanth Ramachandran

Sreekanth Ramachandran has a significant background in medicinal chemistry and drug discovery, with experience at various prestigious companies such as Enveda Biosciences, Syngene International Limited, and AstraZeneca. With a Ph.D in synthetic organic chemistry, Sreekanth has held roles such as Director, Associate Director, Principal Scientist, and Research Scientist. Notably, Sreekanth has been involved in the discovery of novel drug candidates for various medical conditions, including malaria and hospital infections. Additionally, Sreekanth has conducted postdoctoral work at Université de Sherbrooke and Leipzig University, further honing expertise in natural product synthesis and asymmetric catalysis.